drugset / Trial / NCT02016508
Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration
Phase 1/2
Unknown
1 enrolled
Al-Azhar University
Abou el kheir, Wael, M.D. M.Sc. · collabBakry, Sayed , phD. M.Sc. · collabGabr, Hala , M.D. M.Sc. · collabHassan , Hosny , M.D. M.Sc · collabHigazy , Hasan M.D. M.Sc · collabIsmail , Mahmoud M.D. M.Sc · collabSamour , Hany M.D. M.Sc · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this Phase I/II study is to investigate the safety and preliminary efficacy of unilateral intravitreally transplantation of adult bone marrow stem cells in subjects with geographic atrophy secondary to age-related macular degeneration.
Timeline
- Start
- 2013-03
- Primary completion
- 2015-04
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous bone marrow derived stem cells | Cell therapy | 0.1 ml | Intravitreal |